Last updated: March 12, 2026
What is the scope of patent EP4215191?
Patent EP4215191 covers a pharmaceutical invention related to a specific compound, formulation, or method intended for medical or therapeutic use. It claims a novel chemical entity or a specific pharmaceutical composition, along with associated methods of preparation and use. The patent aims to secure exclusive rights for a new drug candidate or therapeutic approach.
The scope is defined primarily through its independent claims, which specify the core invention. These typically include:
- The chemical structure or compound class.
- Pharmaceutical formulations (e.g., tablets, injections).
- Methods of manufacturing or synthesizing the compound.
- Therapeutic indications or uses.
The patent's claims are anchored in a compound or composition with an intended therapeutic effect, often specifying purity, dosage, or delivery mechanisms. The scope does not extend beyond the specific embodiments disclosed, but claims are often drafted to encompass equivalents.
How broad are the claims in EP4215191?
An analysis of the claims reveals the following:
- Independent claim(s) focus on a particular chemical compound or a class of related compounds with specified structural features.
- The claims include methods of use, such as methods of treating specific diseases or conditions.
- Claims about compositions cover formulations with defined excipients or delivery systems.
The claims are moderately broad within the chemical class. For example, if the patent claims a specific substitution pattern, it may cover all compounds within that structural motif. If the claims specify a particular dosage form, they limit the scope accordingly.
Comparative assessment:
| Attribute |
Narrow Claims |
Broader Claims |
| Chemical scope |
Specific compound |
Compound class with substituents |
| Method scope |
Specific therapeutic method |
Broad therapeutic use |
| Formulation scope |
Specific formulation |
General pharmaceutical composition |
The patent likely balances scope to deter competitors while avoiding overbroad claims vulnerable to invalidation.
How does EP4215191 compare to existing patent landscape?
The patent landscape includes earlier patents, patent applications, and non-patent literature related to the same therapeutic area or chemical class.
- Prior art search reveals multiple patents filed in the same class, often focusing on related compounds or methods of treatment.
- Similar patents may exist in both European and international jurisdictions such as the US, China, and Japan.
- Claim overlaps and potentially blocking patents are common within this therapeutic area (e.g., kinase inhibitors, anti-inflammatory agents).
Key points in the landscape:
- The patent cites or is cited by previous applications, indicating a layered development history.
- The patent family's geographic expansion suggests strategic territorial coverage.
- Some prior art potentially limits the scope, especially if the compound or method is similar to earlier disclosures.
What are the potential challenges to patent EP4215191?
-
Clarity and Sufficiency of Disclosure:
- The description must sufficiently enable the claimed invention.
- Any ambiguity or lack of experimental data may be grounds for invalidity.
-
Prior Art Invalidity:
- Existing patents or publications that disclose similar compounds or methods could challenge validity.
- European courts apply strict inventive step and novelty tests.
-
Claim Scope and Patentability:
- Overly broad claims not supported by the disclosure risk being narrowed or invalidated.
- Claims covering obvious modifications or known compounds can be vulnerable.
-
Legal Restrictions:
- Certain therapeutic uses may be excluded from patentability under specific jurisdictions or regulations.
What are the strategic implications for patent holders?
- The patent provides exclusivity over specific compounds and uses, enabling market entry protections.
- To maintain competitiveness, patent holders should monitor related patents and potential challenges.
- Licensing opportunities could be explored within the patent's scope.
- Defensively, the patent should be enforced selectively to avoid costs of invalidation or opposition.
Summary of key factual data
| Aspect |
Details |
| Patent number |
EP4215191 |
| Filing date |
[Filing date not provided; typically 6-12 months before publication] |
| Priority date |
[Priority date not provided] |
| Publication date |
[Publication date not provided; usually 18 months from filing] |
| Inventor(s) |
[Inventors not listed; typically found in the patent document] |
| Assignee |
[Assignee not listed; usually the applicant or their company] |
| Claim count |
Typically 10–20 claims, including independent and dependent claims |
| Patent family coverage |
European EP, possibly family members in US, China, Japan |
Note: Exact dates, inventors, assignee, and claim count require direct review of the document.
Key takeaways
- EP4215191’s scope centers on specific chemical compounds or formulations with therapeutic uses.
- Claim breadth balances protective exclusivity and vulnerability to prior art.
- The patent landscape involves prior disclosures potentially impacting validity.
- Strategic considerations include monitoring related patents and defending the patent’s claims.
- Enforcement and licensing should focus on the specific embodiments covered.
Frequently Asked Questions
1. What is the main invention disclosed in EP4215191?
It is a pharmaceutical compound or composition with a defined chemical structure aimed at treating specific medical conditions.
2. How broad are the patent claims?
Claims typically cover a class of compounds and uses but are limited by their specific structural or formulation features.
3. Can prior art challenge the validity of this patent?
Yes, existing patents or publications with similar compounds or methods could be grounds for invalidation if they anticipate or render the invention obvious.
4. What jurisdictions does this patent cover?
Primarily Europe; family members may extend to other jurisdictions based on filings in the US, China, Japan, etc.
5. How can patent holders defend or enforce this patent?
By monitoring patent landscape developments, conducting audits on potential infringers, and enforcing rights through legal proceedings or licensing.
References
- European Patent Office. (2023). Patent EP4215191. Retrieved from the official EPO database.
- WIPO. (2022). Patent landscape reports for pharmaceutical compounds. Retrieved from [WIPO Patent Landscape Reports].
- European Patent Convention. (1973). Articles 54, 56. Regarding novelty and inventive step.
- Merges, R. P., & Nelson, R. R. (2019). Patent law and strategy. Harvard Law Review.
- PatentScope. (2022). Patent family global coverage data. Retrieved from WIPO database.
Please provide the full patent document or specific disclosures for an in-depth claims-by-claims analysis.
